Navigation Links
Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
Date:2/8/2011

MIAMI, Feb. 8, 2011 /PRNewswire/ -- Attendees at the 2011 Pharmaceutical Care Management Association (PCMA)'s Managed Markets Educational Forum today heard Prime Therapeutics' President and CEO Eric Elliott speak about the critical changes facing pharmaceutical companies and pharmacy benefit managers as health care reform is implemented, industry consolidation increases, a greater number of generics enter the market and the pipeline of new treatments shrinks. Prime Therapeutics is a pharmacy benefit management (PBM) company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members.

"In this time of great change, the industry needs to address the three key areas of cost, quality and access. We need to work together to help patients safely navigate these changes, so that we may continue to deliver the right drugs, at the right time, at affordable prices," Elliott told attendees.

In his keynote address, Elliott spoke about how the industry has evolved and delivered improvements to patient health over the past several decades. In the coming years as more than 30 million patients join the health system, there will be a greater focus on providing higher quality care for patients while increasing value.

"While we may not all agree on each provision of the health care reform law, there are many provisions encouraging better outcomes and better cost management for our patients and clients," said Elliott. "There is an enormous potential to close gaps in care in our country. Whether the potential is realized will depend to a significant degree on how well we do helping patients access and stick to their medications, while managing costs."

Delivered to an audience of pharmaceutical manufacturers and other industry experts, Elliott's speech was the meeting's opening keynote address. The first-annual Managed Markets Educational Forum brings together leaders in the pharmaceutical and pharmacy benefits industries to discuss essential PBM, specialty pharmacy and payer issues.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Greenways PrimeSUITE EHR Featured at IHE North America Connectathon
2. Greenways PrimeSUITE Endorsed by Allina Hospitals & Clinics
3. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
4. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
5. Prime Therapeutics Receives 2011 TIPPS Certification
6. Greenways PrimeSUITE Receives ONC-ATCB 2011/2012 Certification
7. Prime Therapeutics Announces URAC Accreditation
8. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
9. Massachusetts Regional Extension Center Selects Greenways PrimeSuite
10. Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith
11. Siemens Primed to Help Customers Achieve Newly-Defined Criteria for Meaningful Use of an Electronic Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... Pekin, IL (PRWEB) , ... October 13, 2017 ... ... Foundation, which established the certification process to promote standards of excellence for the ... iaedp™ Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
Breaking Medicine News(10 mins):